We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Agreement to Promote Development of Single-Use Biomass Sensors

By LabMedica International staff writers
Posted on 11 Mar 2013
Print article
A recently announced marketing and development agreement focuses on single-use biosensors that are used by the biopharmaceutical industry for obtaining in-line biomass measurements during cell cultivation and fermentation processes.

Sartorius Stedim Biothech (Aubagne, France), a leading provider of equipment and services for development, quality assurance, and production in the biopharmaceutical industry, will be cooperating with Aber Instruments (Aberystwyth, United Kingdom), a global leader in in-line biomass measurement technology. Biomass sensors are high-performance tools for modeling and optimizing biopharmaceutical development and manufacturing processes.

The agreement will give Sartorius exclusive global marketing and distribution rights to Aber's single-use sensor technology for the biopharmaceutical market. Sartorius will manufacture the biomass sensors under license, integrate these into its single-use bioreactors, and exclusively market these products in a dual-branding arrangement. New single-use sensors will be developed by both companies.

"Single-use sensors make our disposable bags even more intelligent," said Stefan Schlack, senior vice president of marketing at Sartorius Stedim Biothech. "They deliver real-time information about the progress of cell culture processes and help biopharmaceutical customers to understand their processes even better and further optimize them – a decisive competitive advantage."

Dr. John Carvell, sales and marketing director at Aber Instruments, said, "Based on Sartorius Stedim Biothech's global sales and distribution network, we can make our technology accessible to an even wider group of customers. Sartorius has in-depth expertise in single-use technology and is thoroughly versed in bioprocesses. Together with our profound knowledge of in-line biomass measurement, both companies stand to benefit from the joint development of new sensors.”

Related Links:

Sartorius Stedim Biothech
Aber Instruments



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.